Our next journal club features two papers on the topic of Bayesian Methods. Please join us to hear Qingzhao Yu (Louisiana State University) and Margaret Gamalo‐Siebers (Eli Lilly & Co) present their recent work:
Qingzhao Yu, 'A Bayesian sequential design with adaptive randomization for 2‐sided hypothesis test'
Authors: Qingzhao Yu, Lin Zhu and Han Zhu
Pharmaceutical Statistics, Vol 16, Issue 6, November/December 2017
Click here to view Qingzhao Yu's presentation
Margaret Gamalo‐Siebers, 'Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluation'
Authors: Margaret Gamalo‐Siebers and the pediatric subteam of the Drug Information Association Bayesian Scientific Working Group and Adaptive Design Working Group
Pharmaceutical Statistics, Vol 16, Issue 4, July/August 2017
Click here to view Margaret Gamalo‐Siebers' presentation
The Chair will be Sara Hughes (GSK).
The event will be held on Thursday 12th July, 3:30-5:00pm (UK time), just block out the date and time in your calendar.
In preparation and prior to the day of the webinar, please find below the link you will need to follow in order to obtain your personal dial in details and register with the webinar software. After registering via this link, you will receive a confirmation email containing information about joining the webinar, including details on how to dial-in via the telephone.
https://attendee.gotowebinar.com/register/1101570305134952706
Please ensure you allow enough time before joining to download the correct software.
Please click here to view the flyer.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
